|
|
Volumn 1, Issue 4, 2004, Pages 183-189
|
|
Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CGMP BINDING, CGMP SPECIFIC 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE;
CGMP-BINDING, CGMP-SPECIFIC 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE;
CYCLIC GMP;
CYCLIC GMP PHOSPHODIESTERASE;
NITRIC OXIDE;
PHOSPHODIESTERASE;
PHOSPHODIESTERASE INHIBITOR;
PIPERAZINE DERIVATIVE;
SILDENAFIL;
ANIMAL;
CONGESTIVE HEART FAILURE;
DRUG ANTAGONISM;
HUMAN;
METABOLISM;
PULMONARY HYPERTENSION;
REVIEW;
3',5'-CYCLIC-GMP PHOSPHODIESTERASE;
ANIMALS;
CYCLIC GMP;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYPERTENSION, PULMONARY;
NITRIC OXIDE;
PHOSPHODIESTERASE INHIBITORS;
PHOSPHORIC DIESTER HYDROLASES;
PIPERAZINES;
|
|
EID: 26044443314
PISSN: 15469530
EISSN: None
Source Type: Journal
DOI: 10.1007/s11897-004-0007-6 Document Type: Review |
|
Times cited : (23)
|
|
References (54)
|
